Literature DB >> 26546212

PPL catalyzed four-component PASE synthesis of 5-monosubstituted barbiturates: Structure and pharmacological properties.

Manisha Bihani1, Pranjal P Bora1, Alakesh K Verma2, Reshita Baruah3, Hari Prasanna Deka Boruah3, Ghanashyam Bez4.   

Abstract

Enzymatic four-component reactions are very rare although three-component enzymatic promiscuous reactions are widely reported. Herein, we report an efficient PASE protocol for the synthesis of potentially lipophilic zwitterionic 5-monosubstituted barbiturates by four component reaction of mixture of ethyl acetoacetate, hydrazine hydrate, aldehyde and barbituric acid in ethanol at room temperature. Seven different lipases were screened for their promiscuous activity towards the synthesis of 5-monosubstituted barbiturates and the lipase from porcine pancreas (PPL) found to give optimum efficiency. The zwitterionic 5-monosubstituted barbiturates with pyrazolyl ring showed promising pharmacological activity upon screening for antibacterial and apoptotic properties.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibacterial; Apoptotic; Barbiturates; PASE; PPL; Pyrazolone; Zwitterionic

Mesh:

Substances:

Year:  2015        PMID: 26546212     DOI: 10.1016/j.bmcl.2015.10.088

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Design and synthesis of novel thiobarbituric acid derivatives targeting both wild-type and BRAF-mutated melanoma cells.

Authors:  Srinivasa Rao Ramisetti; Manoj K Pandey; Sang Y Lee; Deepkamal Karelia; Satya Narayan; Shantu Amin; Arun K Sharma
Journal:  Eur J Med Chem       Date:  2017-11-04       Impact factor: 6.514

Review 2.  Pyrazolone structural motif in medicinal chemistry: Retrospect and prospect.

Authors:  Zefeng Zhao; Xufen Dai; Chenyang Li; Xiao Wang; Jiale Tian; Ying Feng; Jing Xie; Cong Ma; Zhuang Nie; Peinan Fan; Mingcheng Qian; Xirui He; Shaoping Wu; Yongmin Zhang; Xiaohui Zheng
Journal:  Eur J Med Chem       Date:  2019-11-16       Impact factor: 6.514

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.